Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SP4 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | ZNF711 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
mRNA | CTD-2192J16.17 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
mRNA | PARP4 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | TTC33 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
mRNA | RAB33B | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | VAMP8 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | PPM1L | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | SOX9 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
mRNA | RP11-599B13.6 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |